FDA Inspection
Cytovance Biologics Inc.Cytovance Biologics Inc. – FDA Inspection, Jul 20, 2017
Record Details
This FDA Inspection record concerns Cytovance Biologics Inc., with an inspection on July 20, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 23b9870b-a1d7-4890-bb6f-c476414d80b4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1026556
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cytovance Biologics Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 17, 2026 | Not classified | Dallas District Office | |
| May 9, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 27, 2018 | Not classified | Dallas District Office |
Other documents for Cytovance Biologics Inc.
- FDA Inspection 1322570 - 2026-06-17
- FDA Inspection 1089182 - 2019-05-09
- FDA Inspection 1078729 - 2018-04-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.